Rhythm’s Imcivree fails Phase 3 rare form obesity trial
Rhythm’s Imcivree fails Phase 3 rare form obesity trial
Body unavailable. Use the original source.
Rhythm’s Imcivree fails Phase 3 rare form obesity trial
A compact weekly email covering company moves, product signals, regulatory updates, and notable funding.